30-Sep-2019 | Zion Market Research
Zion Market Research has published a new report titled “Inhalation Anesthesia Market By Product (Desflurane, Isoflurane, Sevoflurane, and Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and By Application (Induction and Maintenance): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025”. According to the report, global inhalation anesthesia market was approximately USD 1.24 billion in 2018 and is expected to generate around USD 1.73 billion by 2025, at a CAGR of around 4.9% between 2019 and 2025.
An inhalation anesthetic is a chemical complex holding general anesthetic features that can be transported via inhalation. Inhalation anesthetics are administered through a laryngeal mask airway, face mask, or anesthetic vaporizer with a tracheal tube. General anesthesia is a drug-prompted state that is characterized by the non-existence of awareness to all senses. Chloroform, nitrous oxide, and ether were universally recognized general anesthetics in the past. The most commonly used inhalation anesthetics are desflurane, sevoflurane, and nitrous oxide.
Browse the full “Inhalation Anesthesia Market By Product (Desflurane, Isoflurane, Sevoflurane, and Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and By Application (Induction and Maintenance): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025” Report at https://www.zionmarketresearch.com/report/inhalation-anesthesia-market
Growing emergency and trauma cases, rising cancer incidences, increasing respiratory, cardiovascular, gastrointestinal, neurological, and orthopedic disorders, escalating preference for short hospital stay, increasing number of surgical procedures, various advantages of inhalation anesthesia over intravenous anesthesia, growing load of chronic disorders, access to health insurance coverage, are major driving factors of the inhalation anesthesia market. However, some side effects of inhalation anesthetics, competition from generic versions, less adoption of inhalation anesthetics in some surgical procedures, rigorous government regulations, and lack of awareness may restrict the inhalation anesthesia market globally.
The inhalation anesthesia market is fragmented into product, end-user, and application. Based on the product, the inhalation anesthesia market includes desflurane, isoflurane, sevoflurane, and others. The isoflurane segment is expected to register the highest CAGR in the future. Sevoflurane is expected to dominate the market, with over 61% share, in the future, owing to its multiple advantages like fast recovery and low cost. The end-user segment includes ambulatory surgical centers, hospitals and clinics, and others. Hospitals and clinics dominated the market in 2018, due to the growing demand for various surgeries. Ambulatory surgical centers are expected to register the top-most CAGR over the estimated time period. The application segment comprises maintenance and induction. Maintenance accounted for over 80% of the overall application segment in 2018, due to the requirement of higher volumes for maintenance of inhalation anesthetics. The induction segment is expected to grow rapidly over the projected timeframe.
The North American inhalation anesthesia market will be leading over the forecast time period and accounted for over 40% of the global share in 2018. This can be attributed to the rising chronic diseases, a growing number of surgical procedures, the presence of modern healthcare facilities, and early acceptance of the latest technologies. Europe will hold the second spot in the global market, owing to the presence of trained anesthesiologists, high research and development investment by top companies, growing geriatric population, increasing prevalence of chronic ailments, and encouraging reimbursement scenario. The Asia Pacific will grow rapidly over the forecast period.
Some key players of the inhalation anesthesia market are AbbVie, Lunan Pharmaceutical, Baxter, Halocarbon Products, Hikima Pharmaceuticals, Piramal Enterprises, Fresenius Kabi, and Jiangsu Hengrui Medicine.
This report segments the global inhalation anesthesia market into:
Global Inhalation Anesthesia Market: By Product
Global Inhalation Anesthesia Market: By End-User
Global Inhalation Anesthesia Market: By Application
Global Inhalation Anesthesia Market: By Region
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651